• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Packaging Technology

    Elemental Impurities: The Time Has Come

    Continuous vs. Batch Production

    2018: The evolution of pharmaceutical packaging

    Formulation Development Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Grand River Expands Manufacturing Capacity

    Thermo Fisher Invests $50M to Grow Biologics Footprint

    Q Therapeutics, REPROCELL Form MAGiQ Therapeutics

    Synpromics, Lonza Enter Partnership

    Noramco, SPI Pharma Sign Agreement
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Grand River Expands Manufacturing Capacity

    Thermo Fisher Invests $50M to Grow Biologics Footprint

    Codexis, Porton Enter Collaboration

    WuXi AppTec Opens Laboratory Testing Facility in NJ

    Arcinova Receives £1.5M Innovate UK Grant
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    INTERPHEX: Adents Showcases Cloud-Based Serialization Solution

    Almac Group Expands Packaging Capabilities

    Catalent Bolsters Clinical Supply Capabilities

    West, Stevanato Group Enter Ompi EZ-fill Alliance

    Pharmaceutical Packaging Technology
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Q Therapeutics, REPROCELL Form MAGiQ Therapeutics

    Noramco, SPI Pharma Sign Agreement

    Codexis, Porton Enter Collaboration

    AMRI Expands NMR Spec Capabilities in Europe

    WuXi AppTec Opens Laboratory Testing Facility in NJ
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Blockchain: The Next Big Trend in BioPharma?

    Emergent Completes Market Authorization

    Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle: ICH Q12

    LSNE Expands Capabilities and QC Laboratory Space

    Evotec Launches Drug Development Service
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Piramal Pharma Solutions

    Almac Group

    Fusion Scientific Laboratories

    Rockledge Pharmaceutical Manufacturing, LLC

    iuvo BioScience
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Hepalink To Buy SPL

    Plans to boost heparin API position with $337 million purchase

    Related CONTENT
    • Baxter Suspends Heparin Production
    • Assuring Quality in the Global Supply Chain
    • Quality in the Global Supply Chain for Pharmaceuticals and Medical Devices
    • Supply Chain Focus: Global Quality Issues
    • Sanofi and Innate Pharma Form Immuno-oncology Alliance
    Gil Roth12.26.13
    Hepalink Pharmaceutical Co., Ltd. will acquire Scientific Protein Laboratories, LLC. (SPL), a global API manufacturer, for $337.5 million in cash, plus contingent payments. According to a Hepalink statement, the acquisition will enable the company to expand its presence in the heparin supply market, while providing it with greater product development and growth opportunities in new markets for its line of APIs, including pancreatic enzyme and heparin products. 
     
    Hepalink plans to keep SPL’s management in place, along with its 204 employees in the U.S. SPL’s main facility is in Waunakee, WI. Hepalink is based in Shenzhen, China and has been approved to participate in the U.S. Pharmacopeial Convention’s Pharmaceutical Ingredient Verification Program, which includes rigorous testing, verification and certification of products intended for export to the U.S.
     
    “This represents an exciting opportunity for both companies and all of their employees in an increasingly global industry,” said Li Li, chairman and chief executive officer of Hepalink. “After the acquisition, Hepalink will be able to further enhance the stability and safety of the supply of the heparin product raw materials, strengthen Hepalink’s globally leading advantages in technology, processing techniques, quality and safety standards, and form a global heparin API manufacturing, R&D and distribution network for Hepalink. The transaction will open new markets for API products and allow for greater investment in R&D, new products and processes. Operating at the high level of U.S. and international safety standards, the combined company will continue its absolute commitment to global best practices in product safety and quality as a trusted supplier of ingredients for critical medicines.”
     
    “We are excited about this transaction and what it means for Scientific Protein Laboratories,” said Robert Mills, SPL’s chief executive officer. “This will expand our ability to develop and grow both our domestic and international businesses and to continue to conduct cutting-edge research on new products. We do not anticipate any changes in how we currently do business. We will become part of a very successful company that shares our commitment to safety and quality.”
     
    The parties will file a notice of the transaction with the Committee on Foreign Investment in the U.S. (CFIUS), but they do not expect that any aspects of this transaction will impact U.S. national security. The transaction is currently expected to close during 1H14.
    Related Searches
    • Stability
    • Manufacturing
    • Development
    • Testing
    Suggested For You
    Akebia Therapeutics Names CMO  Akebia Therapeutics Names CMO
    Merck, Stelis Open First Joint Process Scale-Up Lab in Bengaluru Merck, Stelis Open First Joint Process Scale-Up Lab in Bengaluru
    MilliporeSigma Develops New CRISPR Genome Editing Method MilliporeSigma Develops New CRISPR Genome Editing Method
    LSNE, Selecta Biosciences Form Mfg. Pact LSNE, Selecta Biosciences Form Mfg. Pact
    Pierre Fabre Buys Igenica Immuno-oncology Assets Pierre Fabre Buys Igenica Immuno-oncology Assets
    Baxter, ScinoPharm in Strategic Generic Injectables Pact Baxter, ScinoPharm in Strategic Generic Injectables Pact
    STA Pharma Expands Changzhou Site STA Pharma Expands Changzhou Site
    Cambrex Expands Operations in Sweden Cambrex Expands Operations in Sweden
    Contract Manufacturing Budget Trends Contract Manufacturing Budget Trends
    A Mars/Venus Perspective on Sponsor/Contractor Relationships A Mars/Venus Perspective on Sponsor/Contractor Relationships
    Sanofi and Innate Pharma Form Immuno-oncology Alliance Sanofi and Innate Pharma Form Immuno-oncology Alliance
    Supply Chain Focus: Global Quality Issues Supply Chain Focus: Global Quality Issues
    Quality in the Global Supply Chain for Pharmaceuticals and Medical Devices Quality in the Global Supply Chain for Pharmaceuticals and Medical Devices
    Assuring Quality in the Global Supply Chain Assuring Quality in the Global Supply Chain
    Baxter Suspends Heparin Production Baxter Suspends Heparin Production

    Related Breaking News

    • Bio News | Breaking News | Facilities | Industry News
      GE Opens

      GE Opens 'Factory-in-a-Box' for Viral Vector Production

      New factory-in-a-box accelerates the production of viral vector-based therapeutics
      04.17.18

    • Bio News | Breaking News | Industry News
      Wacker Buys Dutch Biotechnology Plant

      Wacker Buys Dutch Biotechnology Plant

      Takes over Synco Bio of Amsterdam; strengthens pharmaceutical protein business
      04.17.18

    • Bio News | Breaking News | Facilities | Industry News
      Lonza Opens Cell and Gene Therapy Mfg. Facility

      Lonza Opens Cell and Gene Therapy Mfg. Facility

      Houston site will produce treatments for rare genetic disorders and life-threatening diseases
      04.10.18


    • Bio News | Breaking News | Collaborations & Alliances | Industry News
      ReForm Biologics, KBI Sign Strategic Agreement

      ReForm Biologics, KBI Sign Strategic Agreement

      To make advanced biopharmaceutical formulations with the goal of enhancing manufacturing efficiencies
      04.04.18

    • Bio News | Breaking News | Industry News
      Therapure Biopharma Launches Biologics Division

      Therapure Biopharma Launches Biologics Division

      New plasma products and technology company-Evolve Biologics-led by Blaine Forshage as CEO
      04.03.18

    • cGMP Manufacture | Industry News
      AGC Biologics Expands U.S. Footprint

      AGC Biologics Expands U.S. Footprint

      New 150,000 sq.-ft. complex will house the company's process development labs and corporate administrative offices
      04.02.18


    • Bio News | Breaking News | Industry News
      Gyros Protein Technologies Upgrades Services

      Gyros Protein Technologies Upgrades Services

      Installs two Gyrolab xPlore systems at Oxford BioMedica for gene and cell therapy applications
      03.29.18

    • Industry News | Reader Showcase
      SSCI Implements New Instruments

      SSCI Implements New Instruments

      Mettler Toledo’s thermal analysis instruments meet the updated regulatory data integrity standards
      03.29.18

    • Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
      Abzena Expands ADC Capabilities

      Abzena Expands ADC Capabilities

      Facility remodeling completed for new ADC GMP manufacturing suite
      03.27.18


    • Bio News | Collaborations & Alliances | Industry News
      Shire & NanoMedSyn Enter Collaboration

      Shire & NanoMedSyn Enter Collaboration

      To evaluate a potential ERT using NanoMedSyn's proprietary synthetic derivatives named AMFA
      03.26.18

    • Bio News | Breaking News | cGMP Manufacture | Facilities | Industry News
      Aldevron Begins Construction of Cleanrooms in $30M GMP Plasmid Facility

      Aldevron Begins Construction of Cleanrooms in $30M GMP Plasmid Facility

      AES Clean Technology to design modular cleanrooms for the $30 million, 70,000 sq. ft. manufacturing facility
      03.23.18

    • Breaking News | Collaborations & Alliances | Industry News
      Innate Biologics Enters Collaboration With The Wistar Institute

      Innate Biologics Enters Collaboration With The Wistar Institute

      Collaboration focused on new approaches to target and treat inflammation at the molecular level
      03.23.18

    • Bio News | Collaborations & Alliances | CRO News | Industry News
      Tergus Pharma Acquires EnDev Laboratories

      Tergus Pharma Acquires EnDev Laboratories

      To add extensive early-phase drug development capabilities from lead compound selection to skin biology
      03.23.18

    • Bio News | Breaking News | Industry News
      Covance Launches Immunology & Immunotoxicology Unit

      Covance Launches Immunology & Immunotoxicology Unit

      The new team will be dedicated to the specific needs of biologic drug development
      03.22.18

    • Bio News | Industry News | Promotions & Moves
      Nabriva Therapeutics Appoints CMO

      Nabriva Therapeutics Appoints CMO

      Dr. Jennifer Schranz joins the company with over two decades of pharmaceutical industry experience
      03.21.18

    Breaking News
    • Grand River Expands Manufacturing Capacity
    • Thermo Fisher Invests $50M to Grow Biologics Footprint
    • Q Therapeutics, REPROCELL Form MAGiQ Therapeutics
    • Synpromics, Lonza Enter Partnership
    • Noramco, SPI Pharma Sign Agreement
    View Breaking News >
    CURRENT ISSUE

    April 2018

    • Pharmaceutical Packaging Technology
    • Elemental Impurities: The Time Has Come
    • Continuous vs. Batch Production
    • 2018: The evolution of pharmaceutical packaging
    • Formulation Development Trends
    • Changing Dynamics: The CDMO market in focus
    • Contract BioManufacturing in China: Creating a New Segment
    • View More >

    Copyright © 2018 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.